UpHealth, Inc. operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; Global Telemedicine; MedQuest Digital Pharmacy, a full-service pharmacy that offers manufactured medication, custom compounded medications, nutraceuticals, lab testing, advocacy, education, etc.; and Behavioral Telehealth solutions. It serves empowering providers, health systems, health plans and governments, employers, and educational institutions. The company is based in Delray Beach, Florida.
IPO Year: 2019
Exchange: NYSE
Website: uphealthinc.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/31/2022 | $6.00 → $1.00 | Buy → Hold | Lake Street |
| 10/25/2021 | $6.00 | Buy | Lake Street |
| 7/22/2021 | $12.00 | Outperform | Oppenheimer |
| 7/13/2021 | $13.00 | Outperform | Northland Capital |
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
SC 13D/A - UpHealth, Inc. (0001770141) (Subject)
SC 13D/A - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
Lake Street downgraded UpHealth from Buy to Hold and set a new price target of $1.00 from $6.00 previously
Lake Street initiated coverage of UpHealth with a rating of Buy and set a new price target of $6.00
Oppenheimer initiated coverage of UpHealth with a rating of Outperform and set a new price target of $12.00
Northland Capital initiated coverage of UpHealth with a rating of Outperform and set a new price target of $13.00
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin BeckAnnounces the Promotion of Lisa Fluxman to President of TTC HealthcareReaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealthDELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replacing
Gainers SenesTech (NASDAQ:SNES) stock rose 42.0% to $2.67 during Monday's after-market session. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 17.71% to $0.49. The market value of their outstanding shares is at $4.6 million. Heart Test Laboratories (NASDAQ:HSCS) stock rose 15.99% to $0.25. The company's market cap stands at $12.0 million. UpHealth (NYSE:UPH) shares rose 10.66% to $0.54. The company's market cap stands at $9.2 million. AcelRx Pharmaceuticals (NASDAQ:ACRX) shares moved upwards by 8.1% to $0.8. The market value of their outstanding shares is at $13.5 million. Sientra (NASDAQ:SIEN) stock rose 7.23% to $0.83. The company's market cap stands at $9.9 million. Losers Cent
Gainers Redhill Biopharma (NASDAQ:RDHL) shares rose 207.0% to $0.97 during Monday's regular session. The company's market cap stands at $10.7 million. Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 119.89% to $6.13. The company's market cap stands at $4.2 million. Tharimmune (NASDAQ:THAR) shares moved upwards by 27.3% to $3.66. The market value of their outstanding shares is at $2.5 million. Lexaria Bioscience (NASDAQ:LEXX) stock rose 24.42% to $1.63. The company's market cap stands at $15.8 million. Mira Pharmaceuticals (NASDAQ:MIRA) stock increased by 21.06% to $3.96. The market value of their outstanding shares is at $58.5 million. Abeona Therapeutics (NASDAQ:ABEO) stock rose 19.0
Shares of Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) surged in pre-market trading after the company announced its foray into the Middle East market. Faraday Future revealed in press release that the company will release the FF 91 2.0 Futurist aiFalcon, with deliveries starting in 2024. Faraday Future shares rose 14.1% to $0.5590 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers FLJ Group Limited (NASDAQ:FLJ) shares rose 126.7% to $0.2451 in pre-market trading. FLJ Group signed a definitive deal to acquire Alpha Mind Technology Limited. Telesis Bio, Inc. (NASDAQ:TBIO) shares rose 37.1% to $0.5482 in pre-market trading after surging
Gainers Heart Test Laboratories (NASDAQ:HSCS) stock rose 22.4% to $0.24 during Thursday's pre-market session. The company's market cap stands at $5.3 million. NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 14.68% to $1.46. The market value of their outstanding shares is at $34.8 million. PaxMedica (NASDAQ:PXMD) stock increased by 13.48% to $0.91. Blue Water Biotech (NASDAQ:BWV) shares increased by 12.11% to $0.36. The company's market cap stands at $6.4 million. The company's, Q3 earnings came out 4 days ago. OpGen (NASDAQ:OPGN) stock rose 11.7% to $0.46. The company's market cap stands at $4.9 million. Avinger (NASDAQ:AVGR) stock increased by 10.63% to $3.33. The company's
Gainers PaxMedica (NASDAQ:PXMD) shares rose 33.6% to $1.07 during Wednesday's regular session. The market value of their outstanding shares is at $1.1 million. Impel Pharmaceuticals (NASDAQ:IMPL) shares increased by 32.68% to $0.42. The company's market cap stands at $10.1 million. BioVie (NASDAQ:BIVI) stock rose 29.03% to $5.6. The company's market cap stands at $211.3 million. Seelos Therapeutics (NASDAQ:SEEL) shares moved upwards by 22.61% to $0.16. The market value of their outstanding shares is at $25.7 million. Heart Test Laboratories (NASDAQ:HSCS) shares rose 22.38% to $0.24. The company's market cap stands at $5.3 million. Agape ATP (NASDAQ:ATPC) stock rose 20.8% to $1.15. The
Gainers Heart Test Laboratories (NASDAQ:HSCS) stock rose 23.9% to $0.24 during Wednesday's pre-market session. The company's market cap stands at $5.3 million. PaxMedica (NASDAQ:PXMD) shares moved upwards by 23.24% to $0.99. The market value of their outstanding shares is at $1.0 million. NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 14.68% to $1.46. The market value of their outstanding shares is at $34.8 million. Apollomics (NASDAQ:APLM) shares increased by 14.18% to $0.92. The company's market cap stands at $81.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 13.99% to $0.57. The market value of their outstanding shares is at $5.3 million. Curis (NASDAQ:CRIS)
Shares of Guess?, Inc. (NYSE:GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance below estimates. Guess? reported quarterly earnings of 49 cents per share, down from the analyst consensus estimate of 62 cents per share, according to data from Benzinga Pro. The company reported quarterly sales of $651.00 million, missing market expectations of $656.03 million. The company lowered its full-year 2024 outlook, expecting revenue growth between 1.8% and 2.4% and adjusted earnings per share between $2.67 and $2.74. Guess shares fell 15.2% to $20.11 in pre-market trading Here are
Gainers Lexaria Bioscience (NASDAQ:LEXX) stock increased by 19.0% to $1.5 during Tuesday's after-market session. The market value of their outstanding shares is at $14.6 million. Personalis (NASDAQ:PSNL) stock rose 11.6% to $1.63. The company's market cap stands at $79.8 million. Atreca (NASDAQ:BCEL) stock increased by 9.47% to $0.23. The company's market cap stands at $9.1 million. Moleculin Biotech (NASDAQ:MBRX) shares moved upwards by 9.15% to $0.57. The company's market cap stands at $16.9 million. Exagen (NASDAQ:XGN) shares increased by 6.44% to $1.65. The company's market cap stands at $27.9 million. China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 6.06% to $1.84. The m
DEFA14A - UpHealth, Inc. (0001770141) (Filer)
8-K - UpHealth, Inc. (0001770141) (Filer)
DEFM14A - UpHealth, Inc. (0001770141) (Filer)
424B3 - UpHealth, Inc. (0001770141) (Filer)
8-K - UpHealth, Inc. (0001770141) (Filer)
PREM14A - UpHealth, Inc. (0001770141) (Filer)
424B3 - UpHealth, Inc. (0001770141) (Filer)
8-K - UpHealth, Inc. (0001770141) (Filer)
424B3 - UpHealth, Inc. (0001770141) (Filer)
8-K - UpHealth, Inc. (0001770141) (Filer)
Second Quarter Revenues Were $37.8 million and Gross Margin Expanded to 53% Year-to-Date Net Loss Attributable to UpHealth, Inc. Improved 9% to $27.2 million Year-to-Date Adjusted EBITDA Improved by $9.2 million to $11.8 million Closed Strategic Sale of Innovations Group, Inc. for $56.0 million Completed Repurchase of $10.3 Million of Convertible Debt Increasing Full Year 2023 Outlook DELRAY BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financi
DELRAY BEACH, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its second quarter ended June 30, 2023, after market close on Thursday, August 10, 2023. A conference call to discuss the results will follow at 5:00 p.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to participate via the telep
First Quarter Revenues Increased 17% to $42.1 millionFirst Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 millionFirst Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023. UpHealth Chief Executive Officer Sam Meckey
DELRAY BEACH, FL, May 09, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its first quarter ended March 31, 2023, after market close on Thursday, May 11, 2023. A conference call to discuss the results will follow at 5:00 p.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to participate via the telephone may d
DELRAY BEACH, FL, Feb. 27, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2022, before the market opens on Thursday, March 2, 2023. A conference call to discuss the results will follow at 8:30 a.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to particip
Second Quarter Revenue of $43.7 million, a 21% increase on a Sequential Basis Gross Margin Expanded to 51%, compared to 43% on a Sequential Basis Nearly 50% of Transformation Initiatives Completed To-Date Subsequent to Quarter End, Company Under New Leadership of CEO Samuel J. Meckey Announced $67.5M Convertible Debt Financing, Further Extending Company's Maturity Profile DELRAY BEACH, Fla., Aug. 15, 2022 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the second quarter ended June 3
DELRAY BEACH, Fla., July 12, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a digital-first healthcare solutions company with a suite of advanced tech products and services to improve population health, today announced that it will release financial results for its second quarter ended June 30, 2022, before the market opens on Monday, August 15, 2022. A conference call to discuss the results will follow at 8:30 a.m. Eastern Time on Monday, August 15, 2022. Those wishing to participate via the webcast should access the call through UpHealth's Inve
Revenue of $36.0 million; Gross Margin of 43% Continued Shift of Revenue Mix to Higher Margin Integrated Care Management and Virtual Care Infrastructure Businesses Substantial Progress Achieved Toward Company-wide Transformation Reiterates 2022 Financial Outlook Settled the Forward Share Purchase Agreement Obligations Subsequent to Quarter End Public Company & Healthcare Industry Veteran Samuel J. Meckey to Become Chief Executive Officer in July DELRAY BEACH, Fla., May 12, 2022 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health managemen
DELRAY BEACH, Fla., April 28, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure and services to modernize care delivery and health management, today announced that it will release financial results for its first quarter ended March 31, 2022, before the market opens on Thursday, May 12, 2022. A conference call to discuss the results will follow at 8:30 a.m. Eastern Time on Thursday, May 12, 2022. Those wishing to participate via the webcast should access the call through
DELRAY BEACH, Fla., Nov. 10, 2021 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the third quarter ended Sept. 30, 2021. "Our first full quarter as a public company marks tremendous growth and success, as we boldly push the integration of our operations and consistently pursue our transformation to a global, leading, digital healthcare, public company. The results convinci
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac
DELRAY BEACH, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth") (OTC:UPHL), a global digital health company delivering a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the arbitration brought by UpHealth Holdings, Inc., a wholly-owned direct subsidiary of UpHealth ("Holdings"), against Glocal Healthcare Systems ("Glocal") and several of Glocal's officers and shareholders (together with Glocal, the "Respondents"). On March 18, 2024, the International Court of Arbitration of the International Chamber of Commerce (the "ICA") transmitted the Final Award to the parties. In the Final
DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "our," "UpHealth," or the "Company") (NYSE:UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024. The $180 million in gross proceeds will be used to pay all closing expenses including any potential liability for taxes on the sale and paying down the Company's debt, including all of the Company's $115 million 2026 Notes and a substantial portion of its $57.2 million 2025 Notes. "This transaction is one m
DELRAY BEACH, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," or the "Company") (NYSE:UPH), today announced that the Company has resumed trading on the New York Stock Exchange ("NYSE") under the symbol "UPH." Trading of UPH resumed, today on November 21, 2023, at market open following the disclosures provided in the November 20, 2023 filings, accessible via the Company's Investor Relations website and the Securities and Exchange Commission at www.sec.gov. About UpHealth, Inc. UpHealth is a global digital health company that delivers digital-first technology, infrastructure, and services to dramatically improve how healthcare is delivered and managed. UpHealt
~ Posts Strong Year Over Year Revenue Growth in Telehealth and Behavioral Health Businesses, Gross Margin Expanded to 54% and $5.4 million in Adjusted EBITDA ~ ~ Reviews in Detail the Voluntary Chapter 11 Protection Filings of One Division of UpHealth, Inc., UpHealth Holdings, Inc., and Certain of its Subsidiaries ~ ~ Entered into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million ~ ~ Simplifies Strategy and Focuses on Profitable TTC, Behavioral Healthcare Business ~ DELRAY BEACH, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "UpHealth," or the "Company") (NYSE:UPH), today issued a corporate update in the form of a letter to shareholders
Leading video-focused language interpretation service provider to become independent company CHICAGO, Nov. 16, 2023 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has signed a definitive agreement to acquire Cloudbreak Health, LLC ("Cloudbreak" or "the Company"), a leading provider of tech-enabled, healthcare-focused language interpretation services, in a corporate carve-out transaction from UpHealth, Inc. ((", UpHealth", , NYSE:UPH). Under the terms of the agreement, the purchase price is $180 million, and the transaction is expected to close in the first quarter of 2024 following the receipt of customary regulatory and stockholder approvals and closing conditi
Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on TTC Healthcare, A Growing, Cash Flow Positive Behavioral Health Business DELRAY BEACH, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), today announced that it has entered into a definitive agreement to sell its wholly-owned subsidiary Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti translation offering, to GTCR for $180 million in cash. GTCR is a leading private equity firm that partners with management leaders to identify, acquire and build market-leading companies through organic growth and strategi
Parent UpHealth, Inc. and its Direct and Indirect Subsidiaries, Cloudbreak Health, LLC and TTC Healthcare, Inc., Have NOT Filed for Chapter 11 Protection and are Operating in the Normal Course of Business Thrasys' Voluntary Reorganization Will Be Consolidated with the September 19, 2023 Chapter 11 Filing of UpHealth Holdings DELRAY BEACH, Fla., Oct. 20, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced Thrasys, Inc. and its sole subsidiary Comprehensive Care Alliance LLC, which has no operations, (co
Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company's next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth's Chie
Intends to use court-supervised process to mitigate financial impact and facilitate a fair resolution through an appeals process following the September 14, 2023 decision by a trial court UpHealth expects to continue operating in the normal course, enabling high quality, affordable and accessible healthcare for all DELRAY BEACH, Fla., Sept. 19, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that its subsidiary, UpHealth Holdings, has filed a voluntary petition for reorganization under Chapter 11 of
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac
Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company's next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth's Chie
Proposed New Independent Board Members Elected Stockholders Approved Reverse Split of the Company's Shares Stockholders Approve New Independent Auditor DELRAY BEACH, Fla., Dec. 05, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) announces the results of its first annual stockholder meeting, held December 5, 2022, virtually. All resolutions submitted for stockholder approval were adopted, including the following: Election of three Class I directors to hold office until the 2025 annual meeting and until their respective successors are elected and qualified.Approval of reverse stock split.Ratification of the appointment of BPM LLP as independent registered public accountin
DELRAY BEACH, Fla., March 9, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE:UPH) today announces the appointment of its new EVP of Integrated Care, Ashish Chona, who joins the UpHealth executive leadership team effective immediately. Chona will oversee operations, delivery, implementation, customer experience and optimization of SyntraNet, UpHealth's integrated care management platform. Chona will also help drive go-to-market plans aligned with UpHealth's core mission to power the world's most trusted health institutions to overcome disparities of access, empower patients and provi
DELRAY BEACH, Fla., Jan. 19, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE:UPH) today announced that expert communications and marketing leader Edna Boone Johnson has joined UpHealth as chief communications and corporate marketing officer, effective immediately. She will report to UpHealth CEO Ramesh Balakrishnan. Johnson will oversee all facets of UpHealth communications and corporate marketing, inclusive of media relations, brand strategy, corporate social responsibility and digital strategy. "Edna's portfolio of experience and expertise will lead how we evangelize our products
DELRAY BEACH, Fla., Nov. 29, 2021 /PRNewswire/ -- UpHealth, Inc. (NYSE:UPH) today announces the appointment of its new Chief People Officer, Darren DeRosa, who joins the UpHealth executive leadership team effective immediately. DeRosa brings a wealth of experience with a proven track record of cross-functional human resources successes spanning more than 30 years. His extensive background encompasses global human resources, business operations and optimization and technology for Fortune 500 companies across industries, including healthcare, pharmaceutical, banking and financi
DELRAY BEACH, Fla., Oct. 20, 2021 /PRNewswire/ -- UpHealth, Inc., (NYSE:UPH) has appointed an experienced health care executive, Sarah Arnquist, to its senior leadership team. Arnquist who joined UpHealth effective immediately, will serve as senior vice president of the Behavioral Health Business. Arnquist is an experienced health care executive with deep understanding of Medicaid policy and delivery systems, especially in the Western U.S. In her role at UpHealth, she will focus on expanding its offerings to health plans and healthcare providers with technology platforms and